Technical Analysis for OPTN - OptiNose, Inc.

Grade Last Price % Change Price Change
grade D 7.46 -5.45% -0.43
OPTN closed down 5.45 percent on Friday, February 21, 2020, on 57 percent of normal volume. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Up
Historical OPTN trend table...

Date Alert Name Type % Chg
Fell Below 200 DMA Bearish 0.00%
Fell Below 20 DMA Bearish 0.00%
Wide Bands Range Expansion 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -5.45%
Crossed Above 200 DMA Bullish -5.45%
Crossed Above 20 DMA Bullish -5.45%
MACD Bullish Signal Line Cross Bullish -5.45%
Wide Bands Range Expansion -5.45%
Up 3 Days in a Row Strength -5.45%
Stochastic Buy Signal Bullish -1.71%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

OptiNose, Inc. is a pharmaceutical company. The Company is focused on the development and commercialization of products for patients treated by ear, nose and throat, or ENT, and allergy specialists. The Company’s products candidates include XHANCE (Nasal Polyps), XHANCE (Chornic Sinusitis) OPN-300, OPN-021, and other. The Company’s lead product, XHANCE (fluticasone propionate) nasal spray, utilizes breath powered exhalation delivery system (EDS), to deliver a topically acting and potent anti-inflammatory corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. XHANCE has a differentiated clinical profile with the potential to become part of the standard of care for this disease because it is able to deliver medication to the primary site of inflammation
Medicine Pharmaceutical Clinical Medicine Organ Systems Disease Inflammation Respiratory Therapy Allergy Glucocorticoids Sinusitis

Is OPTN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 11.66
52 Week Low 4.4431
Average Volume 189,492
200-Day Moving Average 7.76
50-Day Moving Average 8.46
20-Day Moving Average 7.72
10-Day Moving Average 7.31
Average True Range 0.51
ADX 14.69
+DI 23.05
-DI 23.46
Chandelier Exit (Long, 3 ATRs ) 8.11
Chandelier Exit (Short, 3 ATRs ) 8.24
Upper Bollinger Band 8.93
Lower Bollinger Band 6.50
Percent B (%b) 0.39
BandWidth 31.45
MACD Line -0.31
MACD Signal Line -0.37
MACD Histogram 0.0542
Fundamentals Value
Market Cap 281.7 Million
Num Shares 37.8 Million
EPS -19.61
Price-to-Earnings (P/E) Ratio -0.38
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.32
Resistance 3 (R3) 8.36 8.12 8.17
Resistance 2 (R2) 8.12 7.90 8.10 8.12
Resistance 1 (R1) 7.79 7.77 7.67 7.75 8.08
Pivot Point 7.55 7.55 7.49 7.53 7.55
Support 1 (S1) 7.22 7.33 7.10 7.18 6.84
Support 2 (S2) 6.98 7.20 6.96 6.80
Support 3 (S3) 6.65 6.98 6.75
Support 4 (S4) 6.61